We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLI icon
2301
Houlihan Lokey
HLI
$8.77B
$2.31M ﹤0.01%
51,201
+12,828
+33% +$568K
AAXJ icon
2302
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.7B
$2.3M ﹤0.01%
34,743
-2,523
-7% -$169K
LUV icon
2303
CALL
Southwest Airlines
LUV
$23B
$2.3M ﹤0.01%
42,600
+2,400
+6% +$126K
HALO icon
2304
Halozyme
HALO
$9.76B
$2.3M ﹤0.01%
148,163
-78,335
-35% -$1.29M
KMT icon
2305
Kennametal
KMT
$2.66B
$2.3M ﹤0.01%
74,804
-8,735
-10% -$278K
AZTA icon
2306
Azenta
AZTA
$1.38B
$2.3M ﹤0.01%
62,022
-11,251
-15% -$408K
ATI icon
2307
ATI
ATI
$26.4B
$2.29M ﹤0.01%
113,395
+13,666
+14% +$289K
EIDO icon
2308
iShares MSCI Indonesia ETF
EIDO
$484M
$2.29M ﹤0.01%
93,594
+68,788
+277% +$1.74M
ORA icon
2309
Ormat Technologies
ORA
$6.02B
$2.29M ﹤0.01%
30,759
+5,875
+24% +$405K
RWDC
2310
DELISTED
Direxion MSCI Defensives Over Cyclicals ETF
RWDC
$2.28M ﹤0.01%
45,000
-5,000
-10% -$254K
CRC
2311
DELISTED
California Resources Corporation
CRC
$2.28M ﹤0.01%
223,113
+68,427
+44% +$878K
TXT icon
2312
Textron
TXT
$14.9B
$2.27M ﹤0.01%
46,405
-17,054
-27% -$832K
TAK icon
2313
Takeda Pharmaceutical
TAK
$53.7B
$2.27M ﹤0.01%
132,073
-341,690
-72% -$5.91M
NBLX
2314
DELISTED
Noble Midstream Partners LP
NBLX
$2.27M ﹤0.01%
94,026
+84,491
+886% +$2.35M
TYPE
2315
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$2.26M ﹤0.01%
114,198
+88,399
+343% +$1.68M
SPNT icon
2316
SiriusPoint
SPNT
$2.75B
$2.25M ﹤0.01%
225,545
-35,478
-14% -$356K
LUV icon
2317
PUT
Southwest Airlines
LUV
$23B
$2.25M ﹤0.01%
41,700
+3,100
+8% +$162K
MSGN
2318
PUT
DELISTED
MSG Networks Inc.
MSGN
$2.24M ﹤0.01%
+138,300
New +$2.47M
SHOO icon
2319
Steven Madden
SHOO
$3.48B
$2.24M ﹤0.01%
62,575
+4,501
+8% +$149K
BRID icon
2320
Bridgford Foods
BRID
$57.5M
$2.23M ﹤0.01%
74,088
-6,870
-8% -$238K
CNO icon
2321
CNO Financial Group
CNO
$5.16B
$2.23M ﹤0.01%
141,252
-7,616
-5% -$120K
MEDP icon
2322
Medpace
MEDP
$16B
$2.23M ﹤0.01%
26,590
+3,538
+15% +$267K
CUB
2323
DELISTED
Cubic Corporation
CUB
$2.23M ﹤0.01%
31,700
+3,388
+12% +$232K
NET icon
2324
Cloudflare
NET
$100B
$2.23M ﹤0.01%
+120,027
New +$2.32M
SKYW icon
2325
Skywest
SKYW
$4.42B
$2.22M ﹤0.01%
38,592
+23,516
+156% +$1.38M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.